[1]迟显苏,梁 晓,魏竞竞,等.基于血浊理论从痰、瘀、毒论治缺血性脑卒中[J].陕西中医,2023,(7):917-921.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.021]
 CHI Xiansu,LIANG Xiao,WEI Jingjing,et al.Treatment of ischemic stroke from perspective of phlegm blood stasis and poison based on theory of turbid blood[J].,2023,(7):917-921.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.021]
点击复制

基于血浊理论从痰、瘀、毒论治缺血性脑卒中
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年7期
页码:
917-921
栏目:
学术探讨
出版日期:
2023-07-05

文章信息/Info

Title:
Treatment of ischemic stroke from perspective of phlegm blood stasis and poison based on theory of turbid blood
作者:
迟显苏1梁 晓1魏竞竞1刘 悦1刘红喜2朴京泽2(韩国)张允岭1
(1.中国中医科学院西苑医院,北京 100091; 2.北京中医药大学研究生院,北京 100029)
Author(s):
CHI XiansuLIANG XiaoWEI JingjingLIU YueLIU HongxiPIAO JingzeZHANG Yunling
(Xiyuan Hospital,China Academy of Chinese Medical Sciences,Beijing 100091,China)
关键词:
缺血性脑卒中 血浊
Keywords:
Ischemic stroke Turbid blood Phlegm Blood stasis Poison
分类号:
R 255.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.07.021
文献标志码:
A
摘要:
血浊是缺血性脑卒中发病的病理基础,也是其进展、迁延、继发的致病因素。血浊与痰、瘀、毒作用于缺血性脑卒中发生发展的不同时期,又可相互兼夹、相互转化。血脂异常、高血糖、高同型半胱氨酸血症、氧化应激反应、炎症反应、内皮损伤等微观指标赋予“血浊”理论具体意义和临床应用价值。基于血浊理论从痰、瘀、毒角度探讨缺血性脑卒中的防治,可将宏观辨证与微观辨病有机结合,为缺血性脑卒中的中医防治提供微观落脚点。
Abstract:
Turbid blood is not only the pathological basis of onset of ischemic stroke,but also pathogenic factor of its disease progression,delayed healing,and secondary disease.Turbid blood,phlegm,blood stasis and poison play roles in different periods of ischemic stroke,affect each other and cause disease together.The existence of in vivo microscopic indicators such as dyslipidemia,hyperglycemia,hyperhomocysteinemia,oxidative stress response,inflammatory response,and endothelial injury endows the theory of turbid blood with specific significance and clinical application value.Based on the theory of turbid blood,discusses prevention and treatment of ischemic stroke from perspective of phlegm,blood stasis and poison.Organically combine macroscopic syndrome differentiation with microscopic disease differentiation,provide microscopic foothold for prevention and treatment of ischemic stroke.

参考文献/References:

[1] 高长玉,吴成翰,赵建国,等.中国脑梗死中西医结合诊治指南[J].中国中西医结合杂志,2018,38(2):136-144.
[2] 惠小珊,杨 帅,张金生,等.基于量表等级化和主成分分析法探究缺血性中风证候要素与治法间关系[J].中国实验方剂学杂志,2021,27(4):159-167.
[3] 韩 萍,于春蕾,马文香,等.基于治未病理论谈无症状疾病从血浊论治[J].天津中医药,2020,37(6):609-612.
[4] 马 冲,陈 蕾,宋艳艳,等.从血浊论治缺血性脑卒中[J].中国中医急症,2018,27(3):557-558,564.
[5] 朱巍明,刘 伟,张国丽,等.髓亏、气逆、血浊为中风病前三状态[J].中医学报,2021,36(5):924-928.
[6] 刘 艺,侯佳欣,张风霞.从血浊角度浅议缺血性脑卒中的防治[J].世界最新医学信息文摘,2019,19(6):226,228.
[7] 王新陆.血浊理论产生的历史背景和现实意义[J].天津中医药,2019,36(10):937-941.
[8] 齐宝云.试述痰邪在卒中后认知障碍发病过程中的作用[J].中国中医急症,2021,30(10):1764-1766.
[9] 王新陆,王栋先.血浊的生化基础以及与其他病理因素的关系[J].天津中医药,2021,38(1):1-6.
[10] 王新陆,王栋先.血浊的性质特点和辨证论治[J].天津中医药,2020,37(2):148-152.
[11] 李俊哲,黎辉映.“脑心同治”中有关毒邪理论的思考[J].中华中医药杂志,2013,28(6):1660-1663.
[12] 张惜燕,邢玉瑞,胡 勇.中医毒邪研究及相关问题探讨[J].陕西中医药大学学报,2022,45(1):48-52.
[13] 庄慧魁,王栋先,王新陆.血浊与湿、痰饮、瘀、毒之间的病机关系探讨[J].天津中医药,2020,37(8):844-848.
[14] 陈可冀,史大卓,徐 浩,等.冠心病稳定期因毒致病的辨证诊断量化标准[J].中国中西医结合杂志,2011,31(3):313-314.
[15] 史大卓,徐 浩,殷惠军,等.“瘀”“毒”从化——心脑血管血栓性疾病病因病机[J].中西医结合学报,2008,6(11):1105-1108.
[16] 诸骏仁,高润霖,赵水平,等.中国成人血脂异常防治指南[J].中国循环杂志,2016,31(10):937-953.
[17] 凌 丽,耿 赟,方邦江.代谢综合征与脑卒中相关性的中西医认识[J].时珍国医国药,2021,32(10):2479-2481.
[18] 安春耀,李 茹,魏晓倩,等.2型糖尿病患者血浊证候及血浊积分与血糖、血脂等指标的相关性分析[J].世界最新医学信息文摘,2017,17(45):107-108.
[19] Park JH,Lee J,Ovbiagele B.Nontraditional serum lipid variables and recurrent stroke risk[J].Stroke,2014,45(11):3269-3274.
[20] 王翔宇,任红叶,孔 浩.血脂异常与脑卒中的发病风险研究进展[J].世界最新医学信息文摘,2018,18(58):115-116,123.
[21] Law MR,Wald NJ,Rudnicka AR.Quantifying effect of statins on low density lipoprotein cholesterol ischaemic heart disease and stroke:Systematic review and meta-analysis[J].BMJ,2003,326(7404):1423.
[22] Holmes MV,Millwood IY,Kartsonaki C,et al.Lipids lipoproteins and metabolites and risk of myocardial infarction and stroke[J].Journal Am Coll Cardiol,2018,71(6):620-632.
[23] 杜成锋,刘冬宇.血液流变学与血糖及血脂的关系研究[J].贵州医药,2020,44(1):62-64.
[24] 廖凯斌,李潮生.高血糖对血管内皮细胞损伤机制的影响[J].医学综述,2019,25(11):2128-2132.
[25] 盛 明,刘慧霞,张燕柳.晚期糖基化终产物受体基因多态性与缺血性脑卒中遗传易感性的相关性分析[J].中华老年医学杂志,2016,35(2):174-178.
[26] Fonville S,Zandbergen AM,Koudstaal PJ,et al.Prediabetes in patients with stroke or transient ischemic attack:Prevalence risk and clinical management[J].Cerebrovasc Dis,2014,37(6):393-400.
[27] 杨璐萌,程 忻.血糖及侧支循环对急性前循环大动脉缺血性脑卒中预后的影响[J].心脑血管病防治,2020,20(3):229-231,238.
[28] 陈 静,李化强.高同型半胱氨酸血症与脑卒中相关性的研究进展[J].临床医药文献电子杂志,2018,5(25):190-192.
[29] 吕鸿燕,严兴亚,李 凤,等.缺血性脑卒中患者中医证型与Crouse积分、血清同型半胱氨酸、凝血功能相关性研究[J].陕西中医,2021,42(7):879-882.
[30] 柔则古丽?图尔荪,沙地克?沙吾提.缺血性脑卒中与同型半胱氨酸的中西医研究进展[J].新疆中医药,2021,39(5):103-106.
[31] 张艾嘉,王 爽,王 萍,等.缺血性脑卒中的病理机制研究进展及中医药防治[J].中国实验方剂学杂志,2020,26(5):227-240.
[32] 李文静,刘德山.基于炎症因子、血浊论探讨糖尿病动脉粥样硬化的关系[J].世界最新医学信息文摘,2019,19(43):59,61.
[33] 高志芳,陈坚华,潘燕芳,等.炎症因子表达及凝血相关指标在急性进展性脑梗死中的应用价值[J].深圳中西医结合杂志,2018,28(8):44-45.
[34] 于 静,吴晓光.自噬与炎症反应对缺血性脑卒中影响的研究进展[J].承德医学院学报,2021,38(3):239-243.
[35] 林生君,仇 珺,赵 明.通窍醒神方、头针联合经皮穴位电刺激治疗脑卒中临床研究[J].陕西中医,2021,42(2):247-251.
[36] 张 伟,刘晓丹,李 亮,等.益气活血法和行气活血法修复受损血管内皮的实验研究[J].时珍国医国药,2014,25(11):2792-2793.

相似文献/References:

[1]耿银龙,张伟萍,任梦诗.温阳复元方对缺血性脑卒中患者运动功能及生存质量影响研究*[J].陕西中医,2020,(2):172.
 GENG Yinlong,ZHANG Weiping,REN Mengshi..Effect of Wenyang Fuyuan decoction on motor function and quality of life in patients with ischemic stroke[J].,2020,(7):172.
[2]杨 倩,屈 云,王凤英△.脊柱推拿联合康复治疗对缺血性脑卒中患者手功能的影响*[J].陕西中医,2020,(11):1580.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.017]
 YANG Qian,QU Yun,WANG Fengying..Effect of spinal massage combined with routine rehabilitation therapy on recovery from hand dysfunction after ischemic stroke[J].,2020,(7):1580.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.017]
[3]徐亚辉,才丽娜,贺大权,等.活血复健汤治疗脑卒中疗效及对患者神经功能与血清相关指标的影响*[J].陕西中医,2020,(11):1615.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.026]
 XU Yahui,CAI Li'na,HE Daquan,et al.The effect of Huoxue Fujian decoction on cerebral apoplexy and its related indexes of nerve function and serum[J].,2020,(7):1615.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.026]
[4]张锡萍,张斐雪,郑书林,等.血栓通联合吡拉西坦对缺血性脑卒中患者中医证候评分、神经功能及血清NPY、Hcy水平的影响[J].陕西中医,2021,(3):326.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.014]
 ZHANG Xiping,ZHANG Feixue,ZHENG Shulin,et al.Influence of Xueshuantong combined with piracetam on TCM syndrome score neurological function and serum NPY and Hcy in patients with cerebral ischemic stroke[J].,2021,(7):326.[doi:DOI:10.3969/j.issn.1000-7369.2020.03.014]
[5]吕鸿燕,严兴亚,李 凤,等.缺血性脑卒中患者中医证型与Crouse积分、血清同型半胱氨酸、凝血功能相关性研究[J].陕西中医,2021,(7):879.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.017]
 LYU Hongyan,YAN Xingya,LI Feng,et al.Correlation between TCM syndromes and Crouse score,serum Hcy,coagulation function in patients with ischemic stroke[J].,2021,(7):879.[doi:DOI:10.3969/j.issn.1000-7369.2020.07.017]
[6]陈雨菡,马善波,杨 倩,等.黄芪-丹参药对治疗缺血性脑卒中研究进展[J].陕西中医,2021,(8):1142.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
 CHEN Yuhan,MA Shanbo,YANG Qian,et al.Therapeutic effect of Astragali-Salvia miltiorrhiza for ischemic stroke[J].,2021,(7):1142.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.038]
[7]倪广晓,段春巧,周宏斌,等.基于BDNF-Trk B信号通路探讨和血生络方对脑缺血大鼠认知功能的影响及机制研究[J].陕西中医,2021,(11):1481.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.001]
 NI Guangxiao,DUAN Chunqiao,ZHOU Hongbin,et al.Investigated effect of Hexue Shengluo decoction on cognitive function in MCAO rats and mechanism based on BDNF-Trk B signaling pathway[J].,2021,(7):1481.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.001]
[8]王少琴,刘丽彬.子午流注纳子法结合温通针法对缺血性脑卒中患者下肢肢体功能康复及脑血流水平的影响[J].陕西中医,2022,(4):523.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.029]
 WANG Shaoqin,LIU Libin.Effects of Ziwu Liuzhu Nazi method combined with Wentong acupuncture method on lower limb function and cerebral blood flow in patients with ischemic stroke[J].,2022,(7):523.[doi:DOI:10.3969/j.issn.1000-7369.2022.04.029]
[9]吴巧敏,刘金凤,汪艳丽,等.刘如秀教授论治血浊经验[J].陕西中医,2022,(5):624.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.019]
 WU Qiaomin,LIU Jinfeng,WANG Yanli,et al.Professor LIU Ruxiu's experience in treating hyperlipidemia[J].,2022,(7):624.[doi:DOI:10.3969/j.issn.1000-7369.2022.05.019]
[10]郑 勇,程 贝,陈亦辉,等.星蒌承气汤联合丁苯酞治疗缺血性脑卒中疗效及对患者氧化应激、血液流变学的影响[J].陕西中医,2023,(2):191.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.012]
 ZHENG Yong,CHENG Bei,CHEN Yihui,et al.Effect of Xinglou Chengqi decoction combined with butylphthalide on oxidative stress and hemorheology in patients with ischemic stroke[J].,2023,(7):191.[doi:DOI:10.3969/j.issn.1000-7369.2023.02.012]

备注/Memo

备注/Memo:
基金项目:中央级公益性科研院所基本科研业务费专项资金资助项目(ZZ13-024-3); 国家中医药管理局中医药创新团队及人才支持计划项目(ZYYCXTD-C-202007); 国家中医药管理局中医药传承与创新“百千万”人才工程(岐黄学者)项目[国中医药人教发(2018)12号]; 中国中医药循证医学中心业务研究室主任专项课题(2020YJSZX-3); 中国中医科学院科技创新工程项目(CI2021A01301、CI2021A01311); 中国中医科学院中医药防治脑病传承创新团队项目(CI2021B006
更新日期/Last Update: 2023-07-10